PAR-21-124 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS) NOT-NS-23-062 NINDS Feb 6, 2023 Jun 24, 2024 R61/R33, R41/R42, R43/R44
Notice of Special Interest (NOSI): Discovery of Analgesic Natural Products through the NINDS IGNITE Program NOT-AT-20-016 NCCIH Aug 5, 2020 May 8, 2021 R61/R33
For technical issues E-mail OER Webmaster